Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Treasury Shares: 2021-2024

Historic Treasury Shares for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to $450,000.

  • Biofrontera's Treasury Shares fell 8.33% to $412,500 in Q3 2025 from the same period last year, while for Sep 2025 it was $412,500, marking a year-over-year decrease of 8.33%. This contributed to the annual value of $450,000 for FY2024, which is 9331.98% up from last year.
  • According to the latest figures from FY2024, Biofrontera's Treasury Shares is $450,000, which was up 9,331.98% from $4,771 recorded in FY2023.
  • In the past 5 years, Biofrontera's Treasury Shares registered a high of $450,000 during FY2024, and its lowest value of $4,771 during FY2023.
  • Its 3-year average for Treasury Shares is $157,316, with a median of $17,176 in 2022.
  • In the last 5 years, Biofrontera's Treasury Shares crashed by 72.22% in 2023 and then spiked by 9,331.98% in 2024.
  • Biofrontera's Treasury Shares (Yearly) stood at $8,504 in 2021, then spiked by 101.98% to $17,176 in 2022, then slumped by 72.22% to $4,771 in 2023, then skyrocketed by 9,331.98% to $450,000 in 2024.